Full-Time

Radiologic Technologist

Posted on 10/6/2025

Main Line Health

Main Line Health

51-200 employees

Biomedical research division advancing cancer science

No salary listed

Newtown Square, PA, USA

In Person

Category
Medical, Clinical & Veterinary (5)
, , , ,
Requirements
  • ARRT certification (R) or AART or AART eligible technologists hired upon graduation must be certified and registered within 12 months of the hire date to remain employed. The first attempt to certification and registered must take place within 3 months of their hire date.
  • BLS Certification by American Heart Association preferred upon hire, required in timeframe specified in CPR (BLS)/ALS/PALS Policy.
  • Education: IV certification (if applicable)
Responsibilities
  • Performs a variety of Radiology Technology procedures.
  • Exercises professional judgment in performance of services following established protocols and maintains a demeanor complimentary to MLH standards and medical ethics.
  • Provides appropriate care for all patient populations.
  • Demonstrates ability to work independently in provision of services.
Desired Qualifications
  • Minimum recent one year Radiology Technologist experience preferred
  • BLS Certification by American Heart Association preferred upon hire, required in timeframe specified in CPR (BLS)/ALS/PALS Policy.

Lankenau Institute for Medical Research (LIMR) is the research division of Main Line Health that conducts cancer and biomedical research and translates basic science into clinical applications. LIMR studies cell growth and cancer biology, develops discoveries in the lab, and collaborates to move findings into patient care within the health system. It differs from other research centers by its long history as one of the first U.S. cancer-focused institutes, its integration within a hospital-based health system, and its track record of translational research—turning lab findings into clinical therapies and practices. The institute aims to improve patient outcomes by turning basic science into usable medical treatments and interventions for cancer and related diseases.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Lancaster, Pennsylvania

Founded

1927

Simplify Jobs

Simplify's Take

What believers are saying

  • LIMR leads immunotherapy revolution with SYNC-T cryoimmune prostate cancer trial.
  • Main Line Health runs over 35 clinical trials from LIMR innovations.
  • Sharpe-Strumia Foundation bridges LIMR lab discoveries to clinical practice.

What critics are saying

  • Funding cuts halt LIMR IP development and spinouts within 12-24 months.
  • Fox Chase secures 40% more pharma partnerships, diverting LIMR collaborators.
  • SYNC-T trial failure terminates lead program in 18-24 months.

What makes Main Line Health unique

  • LIMR pioneered cancer research in 1927 by studying it as cell growth problem.
  • LIMR discovered Philadelphia chromosome in 1960, launching cancer genetics.
  • LIMR employs ACAPRENEURIAL™ model integrating invention, IP, and spinouts.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Pension

403(b) Retirement Plan

Unlimited Paid Time Off

Tuition Reimbursement

Wellness Program

Family Planning Benefits

Company News

PR Newswire
Nov 22nd, 2024
Independence Blue Cross Launches Epic Payer Platform To Transform Care Coordination And Boost Member Health Outcomes

PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform with health systems and providers in its network to streamline data exchange, close gaps in care, and improve health outcomes for members. Epic Payer Platform is part of Epic, a global healthcare technology company. The platform helps facilitate data exchange and workflow processes for providers and health plans, giving them the insights they need to make care decisions while also saving them time. "We're excited about the implementation of Epic Payer Platform with Drexel Medicine, Jefferson Health, Main Line Health, and Penn Medicine being the first to join us in this transformation. We look forward to more of our health care partners signing on as well," said Michael Vennera, executive vice president and chief strategy, technology, and operations officer at Independence Blue Cross

Managed Healthcare Executive
Feb 16th, 2022
Lankenau Institute For Medical Research hired George Prendergast as president and CEO on Jan 1st 04'.

When George Prendergast was appointed president and CEO of the Lankenau Institute of Medical Research (LIMR) in 2004, he coined the term “acapreneurial” as a mashup for the model he wanted to implement — inventions and startup incubation alongside traditional academic goals of research, new knowledge and its validation.

INACTIVE